Clinicopathological Significance of S100A4 Expression in Non-small Cell Lung Carcinomas.

Eun Ah Jung; Hyun Deuk Cho; Ji Hye Lee; Mee Hye Oh

doi:10.4132/KoreanJPathol.2010.44.5.477

Articles

Page Path: HOME > J Pathol Transl Med > Volume 44(5); 2010 > Article

Original Article Clinicopathological Significance of S100A4 Expression in Non-small Cell Lung Carcinomas.: Eun Ah Jung, Hyun Deuk Cho, Ji Hye Lee, Mee Hye Oh; Journal of Pathology and Translational Medicine 2010;44(5):477-482
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.5.477

Department of Pathology, Soonchunhyang University College of Medicine, Cheonan, Korea. mhoh0212@hanmail.net

3,376 Views
18 Download
6 Crossref
6 Scopus

Full Article

Download PDF

Abstract

BACKGROUND
S100A4 has been implicated in invasion and metastasis of various malignant tumors. The aim of this study was to investigate whether or not S100A4 plays an important role in non-small cell lung carcinomas (NSCLCs).
METHODS
Sixty-seven patients with NSCLC including 37 with squamous cell carcinomas (SCCs) and 30 with adenocarcinomas (ADs) who had undergone surgical resection were analyzed. S100A4 expression was analyzed by immunohistochemistry using tissue microarray blocks.
RESULTS
S100A4 expression was positive in 56 (83.6%) of 67 NSCLC cases. ADs were more frequently S100A4 positive than SCCs (p = 0.017). However, no significant correlation was observed between S100A4 expression and age, gender, pT, pN or tumor, node and metastasis (TNM) stage. Two distant metastatic cases revealed an S100A4 positive reaction. Kaplan-Meier survival curves with the log-rank test showed no correlation with 3-year survival (p = 0.782) or 5-year survival (p = 0.227) in either group of patients according to S100A4 expression.
CONCLUSIONS
S100A4 expression was not correlated with age, gender, pT, pN or TNM stage or survival in patients with NSCLCs. Therefore, S100A4 expression may not be useful as a prognostic marker for NSCLCs. However, S100A4 expression showed a higher positivity in ADs than in SCCs.

Keywords: S100A4 protein, human;Carcinoma, non-small cell lung;Prognosis;

Figure & Data

References

Citations

Citations to this article as recorded by

Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis
Jing Zhang, Yanhui Gu, Xiaoli Liu, Ximin Rao, Guichuan Huang, Yao Ouyang
Bioscience Reports.2020;[Epub] CrossRef
S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation
TENG HUA, SHUANGGE LIU, XIAOYAN XIN, LIQIONG CAI, RUI SHI, SHUQI CHI, DILU FENG, HONGBO WANG
Oncology Reports.2016; 35(6): 3419. CrossRef
Prognostic value of cytoplasmic expression of S100A4 protein in endometrial carcinoma
HYE IN CHONG, JEONG HEE LEE, MAN SOO YOON, DONG SOO SUH, KYUNGBIN KIM, JEE YEON KIM, KYUNG UN CHOI
Oncology Reports.2014; 31(6): 2701. CrossRef
Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma
Hua Zhang, Jun Liu, Dongsheng Yue, Liuwei Gao, Daowei Wang, Hongdian Zhang, Changli Wang
Journal of Clinical Pathology.2013; 66(11): 937. CrossRef
Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer
Ane Kongsgaard Rud, Marius Lund-Iversen, Gisle Berge, Odd Terje Brustugun, Steinar K Solberg, Gunhild M Mælandsmo, Kjetil Boye
BMC Cancer.2012;[Epub] CrossRef
Clinicopathologic Implication of Ezrin Expression in Non-small Cell Lung Cancer
Ho Won Lee, Eui Han Kim, Mee-Hye Oh
Korean Journal of Pathology.2012; 46(5): 470. CrossRef

Cited

Related articles